NCT07165132 2026-04-13Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.RayzeBio, Inc.Phase 1 Recruiting104 enrolled
NCT05199584 2026-03-05A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsEndeavor Biomedicines, Inc.Phase 2 Completed20 enrolled
NCT03600233 2025-12-23Study of CVM-1118 for Patients With Advanced Neuroendocrine TumorsTaiRx, Inc.Phase 2 Active not recruiting34 enrolled
NCT05997056 2024-07-16Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR InhibitorsAadi Bioscience, Inc.Phase 2 Recruiting21 enrolled
NCT02355535 2020-09-24Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1Vanquish Oncology, Inc.Phase 1 Completed48 enrolled
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled